Over the past decade, health insurance companies have increasingly embraced the use of artificial intelligence algorithms – ...

Corcept Therapeutics Incorporated (NASDAQ:CORT) is a California-based company specializing in cortisol modulation through ...

— Help teens recognize that AI companions are programmed to be agreeable and validating. Explain that’s not how real ...

Teenagers are increasingly turning to AI for advice, emotional support and decision-making, according to a new study.

Avidity Biosciences saw its share prices increase by 9.21 percent on Friday to end at $36.27 apiece as investor sentiment was bolstered by the Food and Drug Administration’s (FDA) breakthrough ...

Researchers at Johns Hopkins University have developed SRT-H, an AI that autonomously guided a da Vinci robot through complex ...

Welcome to this week’s Food Exec Brief, a roundup of the most important news shaping food and beverage manufacturing, from ...

Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...

Current and former members of the FDA told CNN about issues with the Elsa generative AI tool unveiled by the federal agency last month. Three employees said that in practice, Elsa has hallucinated ...

The White House has released “America’s AI Action Plan,” a national strategy to accelerate AI adoption across key sectors — with healthcare identified as a top priority for reform, innovation and ...

The FDA's 'Elsa' AI, intended to speed up drug approvals, is reportedly fabricating studies, part of a wider trend of unreliable AI in high-stakes roles.

The FDA's generative AI, Elsa, has a massive hallucination problem, according to the agency's employees themselves.